PLASMA activities of coagulation factors II (prothrombin), VII (proconvertin), IX (Christmas factor) and X (Stuart factor) have in common 3 generally recognized characteristics: these activities are ...

A new concentrate of clotting factors II, VII, IX and X, made from pooled human plasma collected in citrate anticoagulant by a process involving the adsorption of the effluent from Cohn fraction I on ...

Rare clotting factor deficiencies are a collection of bleeding disorders associated with issues with clotting factors. These conditions are inherited and target the proteins in the blood that control ...

Researchers have made several, subtle changes in the structure of a key protein, dramatically increasing its ability to drive blood clotting, according to a new study. The findings have profound ...

Please provide your email address to receive an email when new articles are posted on . Since the introduction of aggressive hemophilia prophylaxis in Sweden in the 1960s, there has been a dramatic ...

The severity of factor X deficiency varies from person to person. Your body still produces 40% or more of the normal amount of factor X in mild cases. You may have no symptoms or only very minor ones.

Credit: Octapharma. Balfaxar is a human plasma-derived, purified, virus inactivated and nanofiltered non-activated prothrombin complex concentrate. Balfaxar ® (prothrombin complex concentrate, ...

All that most laymen know about hemophilia is that it is an odd and dangerous disease of the blood that strikes men only, although it is transmitted by women. Medical researchers have learned a great ...

Coagulation factors, which are involved in blood clotting after injury, may offer new strategies for fighting multidrug-resistant bacteria, according to a new study. Coagulation factors, which are ...